
NovaBioAssays
Woburn, MA, United States novabioassays.com From their website, Nov 2026
Work here? Claim this listing
About
NovaBioAssays is a contract research organization in Woburn, Massachusetts that provides analytical and bioanalytical services for biopharma, biotech, and academic clients. It supports drug discovery and development across protein, antibody, ADC, oligonucleotide, small molecule, and gene therapy programs.
NovaBioAssays is a CRO in Woburn, MA, founded in 2012. It lists 20 services, including Non-regulated Bioanalysis, Exploratory Biomarker Analysis and HDX-MS: Epitope Mapping.
Services
Non-regulated Bioanalysis
Provides bioanalytical support for discovery and development studies.
Exploratory Biomarker Analysis
Develops and runs biomarker assays to support discovery projects.
HDX-MS: Epitope Mapping
Performs HDX-MS-based epitope mapping for therapeutic proteins and antibodies.
Whole Blood Stability: ADC
Evaluates whole blood stability for ADC programs.
In Vivo Biotransformation
Supports in vivo biotransformation studies for ADC programs.
De Novo Sequencing Development
Develops de novo sequencing workflows for protein characterization.
Host Cell Protein (HCP) Analysis
Analyzes host cell protein impurities in biologic samples.
Analytical Characterization
Provides extended analytical characterization for biologics.
12 more services
- Forced Degradation Analysis
- PTM/Charge Variant/Sequence Variant Analysis
- N and O Glycosylation
- Elucidation of Structure
- Analytical Method Development and Qualification
- Impurity Profiling
- Accelerated Stress and Forced Degradation Study
- Reference Standard Characterization
- Oligonucleotide Quantitative Bioanalysis
- Oligonucleotide Characterization
- Small Molecule Bioanalysis
- Metabolite ID/Profiling
How to order from NovaBioAssays
They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.
Capabilities
- Assays and studies
- Bioanalysis
- Oligonucleotides
- Small molecules
- ADCs
- Analytical development
- ADME
17 more
- In vivo
- Antibodies
- LC-MS/MS
- ELISA
- Analytical characterization
- Epitope mapping
- HDX-MS
- LC-HRMS
- LC-fluorescence
- Hybridization ELISA
- Biomarker assay development
- Ligand-binding assays
- Forced degradation
- Glycosylation analysis
- HCP analysis
- ADME assays
- Metabolite profiling
- Scale and capacity
- Full occupancy of a two-story laboratory building
- Therapeutic areas
- Drug discovery
- Drug development
Instruments and platforms
- State-of-the-art instrumentation
- Triple quadrupole mass spectrometry
- High-resolution mass spectrometry
- LC-MS/MS
- LC-HRMS
- LC-fluorescence
- Hybridization ELISA
Modalities and species
- Modalities
- Small molecule
- Antibody
- ADC
- Oligonucleotide
- Species and models
- Cell-based assays
- Animal studies
- Whole blood
- Target cells
- Tissues
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Details
- Type
- CRO
- Founded
- 2012
- Ownership
- Small business, as registered with SAM.gov or stated on their site
- Based in
- Woburn, MA, United States
- Serves
- Global biotech and pharmaceutical industry, across the country, internationally